BRIT J CANCER - British journal of cancer

Publications

  1. 2013
  2. Dietary patterns and survival in German postmenopausal breast cancer survivors.

    Vrieling, A., Buck, K., Seibold, P., Heinz, J., Obi, N., Flesch-Janys, D. & Chang-Claude, J., 2013, In: BRIT J CANCER. 108, 1, p. 188-192 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2012
  4. Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

    Xylinas, E., Cha, E. K., Sun, M., Rink, M., Trinh, Q-D., Novara, G., Green, D. A., Pycha, A., Fradet, Y., Daneshmand, S., Svatek, R. S., Fritsche, H-M., Kassouf, W., Scherr, D. S., Faison, T., Crivelli, J. J., Tagawa, S. T., Zerbib, M., Karakiewicz, P. I. & Shariat, S. F., 20.11.2012, In: BRIT J CANCER. 107, 11, p. 1826-1832 7 p., 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.

    von Bueren, A., Bacolod, M. D., Hagel, C., Heinimann, K., Fedier, A., Kordes, U., Pietsch, T., Koster, J., Grotzer, M. A., Friedman, H. S., Marra, G., Kool, M. & Rutkowski, S., 09.10.2012, In: BRIT J CANCER. 107, 8, p. 1399-1408 10 p., 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.

    Nitzsche, B., Gloesenkamp, C., Schrader, M., Hoffmann, B., Zengerling, F., Balabanov, S., Honecker, F. & Höpfner, M., 2012, In: BRIT J CANCER. 107, 11, p. 1853-1863 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

    Roy, A., Cunningham, D., Hawkins, R., Sörbye, H., Adenis, A., Barcelo, J-R., Lopez-Vivanco, G., Adler, G., Canon, J-L., Lofts, F., Castanon, C., Fonseca, E., Rixe, O., Aparicio, J., Cassinello, J., Nicolson, M., Mousseau, M., Schalhorn, A., D'Hondt, L., Kerger, J., Hossfeld, D., Garcia Giron, C., Rodriguez, R., Schoffski, P. & Misset, J-L., 2012, In: BRIT J CANCER. 107, 3, p. 435-441 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.

    Dieckmann, K-P., Spiekermann, M., Balks, T., Flor, I., Löning, T., Bullerdiek, J. & Belge, G., 2012, In: BRIT J CANCER. 107, 10, p. 1754-1760 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.

    Witzel, I., Loibl, S., von Minckwitz, G., Eidtmann, H., Fehm, T., Khandan, F., Schmatloch, S., Hauschild, M., Bischoff, J., Fasching, P. A., Mau, C., Schem, C., Rack, B., Meinhold-Heerlein, I., Liedtke, C., Karn, T., Huober, J., Zu Eulenburg, C. G., Issa-Nummer, Y., Untch, M. & Müller, V., 2012, In: BRIT J CANCER. 107, 6, p. 956-960 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 2011
  11. Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

    Hofstetter, G., Berger, A., Schuster, E., Wolf, A., Hager, G., Vergote, I., Cadron, I., Sehouli, J., Braicu, E. I., Mahner, S., Speiser, P., Marth, C., Zeimet, A. G., Ulmer, H., Zeillinger, R. & Concin, N., 08.11.2011, In: BRIT J CANCER. 105, 10, p. 1593-9 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.

    Kornfeld, J., Meder, S., Wohlberg, M., Friedrich, R., Rau, T., Riethdorf, L., Löning, T., Pantel, K. & Riethdorf, S., 04.01.2011, In: BRIT J CANCER. 104, 1, p. 138-145 8 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.

    Friend, E., Yadegarfar, G., Byrne, C., Johnson, C. D., Sezer, O., Pucciarelli, S., Pereira, S. P., Chie, W-C., Banfield, A., Ramage, J. K. & Group, EORTC. Q. O. L., 2011, In: BRIT J CANCER. 104, 4, p. 587-592 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer.

    Buck, K., Zaineddin, A. K., Vrieling, A., Heinz, J., Linseisen, J., Flesch-Janys, D. & Chang-Claude, J., 2011, In: BRIT J CANCER. 105, 8, p. 1151-1157 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer.

    Stecker, K., Vieth, M., Koschel, A., Wiedenmann, B., Röcken, C. & Anders, M., 2011, In: BRIT J CANCER. 104, 9, p. 1426-1433 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 2010
  17. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

    Schwarz, J., Tiling, R., Avril-Sassen, S., Mahner, S., Lebeau, A., Weber, C., Schwaiger, M., Jänicke, F., Untch, M. & Avril, N., 2010, In: BRIT J CANCER. 102, 1, p. 35-41 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

    Henningsen, M., Wirtz, R. M., Kalogeras, K. T., Milde-Langosch, K., Schmidt, M., Witzel, I., Eleftheraki, A. G., Papadimitriou, C., Jänicke, F., Briassoulis, E., Pectasides, D., Rody, A., Fountzilas, G. & Müller, V., 2010, In: BRIT J CANCER. 103, 7, p. 1048-1056 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.

    Köhler, S., Ullrich, S., Richter, U. & Schumacher, U., 2010, In: BRIT J CANCER. 102, 3, p. 602-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2009
  21. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment.

    Slade M, J., Payne, R., Riethdorf, S., Ward, B., Zaidi S, A. A., Stebbing, J., Palmieri, C., Sinnett, H. D., Kulinskaya, E., Pitfield, T., McCormack, R. T., Pantel, K. & Coombes, R. C., 2009, In: BRIT J CANCER. 100, 1, p. 160-166 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure.

    Kettunen, E., Aavikko, M., Nymark, P., Ruosaari, S., Wikman, H., Vanhala, E., Salmenkivi, K., Pirinen, R., Karjalainen, A., Kuosma, E. & Anttila, S., 2009, In: BRIT J CANCER. 100, 8, p. 1336-1342 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer.

    Andersen, C. L., Christensen, L. L., Thorsen, K., Schepeler, T., Sørensen, F. B., Verspaget, H. W., Simon, R., Kruhøffer, M., Aaltonen, L. A., Laurberg, S. & Ørntoft, T. F., 2009, In: BRIT J CANCER. 100, 3, p. 511-523 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Loss of Coxsackie and adenovirus receptor downregulates alpha-catenin expression.

    Stecker, K., Koschel, A., Wiedenmann, B. & Anders, M., 2009, In: BRIT J CANCER. 101, 9, p. 1574-1579 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

    Anders, M., Vieth, M., Röcken, C., Ebert, M., Pross, M., Gretschel, S., Schlag, P. M., Wiedenmann, B., Kemmner, W. & Höcker, M., 2009, In: BRIT J CANCER. 100, 2, p. 352-359 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2008
  27. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients

    Blechschmidt, K., Sassen, S., Schmalfeldt, B., Schuster, T., Höfler, H. & Becker, K-F., 29.01.2008, In: BRIT J CANCER. 98, 2, p. 489-95 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

    Mahner, S., Baasch, C., Schwarz, J., Hein, S., Wölber, L., Jänicke, F. & Milde-Langosch, K., 2008, In: BRIT J CANCER. 99, 8, p. 1269-1275 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

    Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Barrels, K., Horn, C., Stahl, T., Cao, Y., Milde-Langosch, K., Niendorf, A., Kröger, N., Wenzel, S., Leuwer, R., Bokemeyer, C., Hegewisch-Becker, S. & Atanackovic, D., 2008, In: BRIT J CANCER. 99, 6, p. 930-938 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model.

    Dahl, A., Dautel, P., Meyer, A., Pfüller, U. & Schumacher, U., 2008, In: BRIT J CANCER. 98, 1, p. 106-112 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease.

    Helms, M. W., Kemming, D., Pospisil, H., Vogt, U., Buerger, H., Korsching, E., Liedtke, C., Schlotter, C. M., Wang, A., Chan, S. Y. & Brandt, B., 2008, In: BRIT J CANCER. 99, 5, p. 774-780 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Tallness is associated with risk of testicular cancer: evidence for the nutrition hypothesis.

    Dieckmann, K-P., Hartmann, J. T., Classen, J., Lüdde, R., Diederichs, M. & Pichlmeier, U., 2008, In: BRIT J CANCER. 99, 9, p. 1517-1521 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. 2007
  34. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.

    Dahl, A., Mauer, S., Fodstad, O. & Schumacher, U., 2007, In: BRIT J CANCER. 96, 4, p. 609-616 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Gene expression profiling for the diagnosis of acute leukaemia.

    Haferlach, T., Kohlmann, A., Bacher, U., Schnittger, S., Haferlach, C. & Kern, W., 2007, In: BRIT J CANCER. 96, 4, p. 535-540 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Temozolomide as salvage treatment in primary brain lymphomas.

    Reni, M., Zaja, F., Mason, W., Perry, J., Mazza, E., Spina, M., Bordonaro, R., Ilariucci, F., Faedi, M., Corazzelli, G., Manno, P., Franceschi, E., Pace, A., Candela, M., Abbadessa, A., Stelitano, C., Latte, G. & Ferreri, A. J. M., 2007, In: BRIT J CANCER. 96, 6, p. 864-867 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 2006
  38. Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

    Hannemann, J., Kristel, P., van Tinteren, H., Bontenbal, M., van Hoesel, Q. G. C. M., Smit, W. M., Nooij, M. A., Voest, E. E., van der Wall, E., Hupperets, P., de Vries, E. G. E., Rodenhuis, S. & van de Vijver, M. J., 20.11.2006, In: BRIT J CANCER. 95, 10, p. 1334-41 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Factors associated with emotional and behavioural problems among school age children of breast cancer patients

    Watson, M., St James-Roberts, I., Ashley, S., Tilney, C., Brougham, B., Edwards, L., Baldus, C. & Romer, G., 2006, In: BRIT J CANCER. 94, 1, p. 43-50

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

    Went, P., Vasei, M., Bubendorf, L., Terracciano, L., Tornillo, L., Riede, U., Kononen, J., Simon, R., Sauter, G. & Baeuerle, P. A., 2006, In: BRIT J CANCER. 94, 1, p. 128-135 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.

    Christoph, F., Kempkensteffen, C., Weikert, S., Köllermann, J., Krause, H., Miller, K., Schostak, M. & Schrader, M., 2006, In: BRIT J CANCER. 95, 12, p. 1701-1707 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.

    Goekkurt, E., Hoehn, S., Wolschke, C., Wittmer, C., Stueber, C., Hossfeld, D. K. & Stoehlmacher, J., 2006, In: BRIT J CANCER. 94, 2, p. 281-286 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Stressful life events and cancer risk.

    Bergelt, C., Prescott, E., Grønbaek, M., Koch, U. & Johansen, C., 2006, In: BRIT J CANCER. 95, 11, p. 1579-1581 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. 2005
  45. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.

    Milde-Langosch, K., Bamberger, A-M., Rieck, G., Grund, D., Hemminger, G., Müller, V. & Löning, T., 2005, In: BRIT J CANCER. 92, 12, p. 2206-2215 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. 2004
  47. Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

    Hofheinz, R-D., Hartmann, J. T., Willer, A., Oechsle, K., Hartung, G., Gnad, U., Saussele, S., Kreil, S., Bokemeyer, C., Hehlmann, R. & Hochhaus, A., 31.08.2004, In: BRIT J CANCER. 91, 5, p. 834-8 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Repair of radiation damage to DNA.

    Willers, H., Dahm-Daphi, J. & Powell, S. N., 2004, In: BRIT J CANCER. 90, 7, p. 1297-1301 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Sentinel lymph-node biopsy in head and neck cancer.

    Höft, S., Maune, S., Muhle, C., Brenner, W., Czech, N., Kampen, W-U., Jänig, U., Laudien, M., Gottschlich, S. & Ambrosch, P., 2004, In: BRIT J CANCER. 91, 1, p. 124-128 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. 2003
  51. Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

    Hartmann, J. T., Oechsle, K., Quietzsch, D., Wein, A., Hofheinz, R. D., Honecker, F., Nehls, O., Köhne, C-H., Käfer, G., Kanz, L. & Bokemeyer, C., 01.12.2003, In: BRIT J CANCER. 89, 11, p. 2051-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.

    Kaaijk, P., Kaspers, G. J. L., Van Wering, E. R., Broekema, G. J., Loonen, A. H., Hählen, K., Schmiegelow, K., Janka-Schaub, G., Henze, G., Creutzig, U. & Veerman, A. J. P., 2003, In: BRIT J CANCER. 88, 5, p. 775-781 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks.

    El-Awady, R. A., Dikomey, E. & Dahm-Daphi, J., 2003, In: BRIT J CANCER. 89, 3, p. 593-601 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. 2002
  55. Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

    Bokemeyer, C., Oechsle, K., Hartmann, J. T., Schöffski, P., Schleucher, N., Metzner, B., Schleicher, J. & Kanz, L., 04.11.2002, In: BRIT J CANCER. 87, 10, p. 1066-71 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET

    Bokemeyer, C., Kollmannsberger, C., Oechsle, K., Dohmen, B. M., Pfannenberg, A., Claussen, C. D., Bares, R. & Kanz, L., 12.02.2002, In: BRIT J CANCER. 86, 4, p. 506-11 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. 2001
  58. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.

    Milde-Langosch, K., Goemann, C., Methner, C., Rieck, G., Bamberger, A. M. & Löning, T., 17.08.2001, In: BRIT J CANCER. 85, 4, p. 546-551 6 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation.

    Dahl, A., Moll, I., Berger, J. & Schumacher, U., 2001, In: BRIT J CANCER. 84, 6, p. 819-823 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  60. 2000
  61. Expression of human milk fat globulin proteins in cells of haemopoietic origin.

    Krüger, W., Lohner, R., Jung, R., Kröger, N. & Zander, A. R., 2000, In: BRIT J CANCER. 83, 7, p. 874-879 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. 1999
  63. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components

    Haier, J., Nasralla, M. & Nicolson, G. L., 08.1999, In: BRIT J CANCER. 80, 12, p. 1867-74 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  64. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

    Kuhn, W., Schmalfeldt, B., Reuning, U., Pache, L., Berger, U., Ulm, K., Harbeck, N., Späthe, K., Dettmar, P., Höfler, H., Jänicke, F., Schmitt, M. & Graeff, H., 04.1999, In: BRIT J CANCER. 79, 11-12, p. 1746-51 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  65. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes.

    Jung, R., Petersen, K., Krüger, W., Wolf, M., Wagener, C., Zander, A. & Neumaier, M., 1999, In: BRIT J CANCER. 81, 5, p. 870-873 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review